Pierre PAYOUX

PU-PH

Travaille sur

Abstracts rédigés ou co-rédigés

> La réflexologie plantaire modifie la connectivité cérébrale chez des volontaires sains : un essai randomisé contrôlé en IRMf de repos
Mathilde Boussac, Karel Joineau, Pierre Payoux, Emeline Descamps
11 eme Congres Scientifique sur les Interventions Non Médicamenteuses (INM)
Montpellier France
> Neuroinflammation au stade prodromal de la maladie d’Alzheimer : une étude transversale en imagerie TEP de TSPO.
Dominique Gouilly, Maëva Fisher, Patrice Péran, Anne-Sophie Salabert, Elsa Bertrand, Marie Goubeaud, Johanne Germain, Béatrice Lemesle, Claire Thalamas, Camille Tisserand, Marie Rafiq, Marie Benaiteau, Jasmine Carlier, Pierre Payoux, Jérémie Pariente
Congrès francophone RFMASA Rencontre Francophone sur la Maladie d’Alzheimer et Syndromes Apparentés, 22-24 septembre 2021, Marseille.
> Cognitive change in frail individuals with intermediate amyloid load: insight from the MAPT interventional study
Laure Saint-Aubert, Isabelle Carrié ,Anne Hitzel, Anne-Sophie Salabert, Pierre Payoux
7ème Journées Françaises de Médecine Nucléaire 2021 (JFMN), 02-04 septembre 2021, Montrouge.
> Antibody anti-PDL1 radiolabelling with 89Zr : feasibility and in vitro characterization
Anis KRACHE, Charlotte FONTAN, Pierre PAYOUX, Anne-Sophie SALABERT, Mélanie WHITE-KONING
4th Nuclear Technologies for Health Symposium, 13-14 février 2020, Nantes
> Innovative technical platform in radiochemistry and radiopharmacy (PiR-2)
Perez M, Meligne D, Salabert A-S, Gros-Dagnac H, Gras E, Fontan C, Lacoste E, Tafani M, Payoux P
Congrès Toulouse Onco Week, 1-5 février 2020, Toulouse
> Preliminary results : effect of p38α MAPK inhibitor on neuroinflammation assessed by DPA-714 in early Alzheimer disease
Dominique Gouilly , Béatrice Lemesle, Elsa Pomies , Johanne Germain, Pierre Payoux , Mathieu Tafani, Anne-Sophie Brun-Salabert , Claire Thalamas, Marie Benaiteau , Jasmine Carlier, Fabienne Calvas , Patrice Péran , Jérémie Pariente.
8èmes Rencontres de la Fondation Alzheimer, 19-20 novembre 2019, Paris
> Absence of correlation between complaint and visual alterations in PCA patients: A FGD-PET controlled study.
Guerrier L., Cransac C., Pagès B., Saint-Aubert L., Payoux P.,Péran P., Pariente J.
5th Congress of the European Academy of Neurology, EAN 2019, 29 juin- 2 Juillet 2019 à Oslo, Norvège.
> Functional connectivity changes in resting state MRI after donepezil treatment in healthy participants
P Péran, A.-S Salabert, T. Dondaine, J. Sein, J.A. Gutierrez, X. Leclerc, H. Gros-Dagnac, J Llido, J.-P. Ranjeva, R. Lopes, L. Lanteaume, O. Blin, C Thalamas, R Bordet, P Payoux, PharmaCog Consortium
8th European Conference onClinical Neuroimaging, 20-21 Mai 2018, Bruxelles, Belgique.
> Quantitative imaging of cell viability after graft in stroke rodent model with [18F]FHBG.
Salabert A.S, Vaysse L, Beaurain M, Alonso M, Besombes J, Loubinoux I, Tafani M, Payoux P
Congrés EANM - European Association of Nuclear Medicine - BARCELONE
> Évaluation de la biologie et de la dosimétrie de la [18F] FNM basée sur de l’imagerie préclinique PET
A.S. Salabert, E. Mora Ramirez, M. Beaurain, M. Alonso, C. Fontan, H. Belhadg Tahar, M. Tafani, M. Bardiés, P. Payoux
JFMN17: 3es Journées Francophones de Médecine Nucléaire - NANTES
> Cortex cingulaire et anosognosie dans la Maladie d’Alzheimer : étude en imagerie multimodale
Laura Guerrier, Johanne Le Men, Anaïs Gane, Mélanie Planton, Anne-Sophie Salabert, Pierre Payoux, Hervé Dumas, Fabrice Bonneville, Patrice Péran, Jérémie Pariente
41ièmes Journées de Printempsde SNLF - GRENOBLE Obtenu Prix de la meilleure communication orale
> FMRI study of Memantineand Donepezil effect on cerebral activation in WM task and sleep deprivation
Abdel-kaderBoulanouar, Jean-Philippe Ranjeva, Renaud Lopes, J. Micaleff, D. Delplanque, Déborah Meligne, Régis Bordet, Jorge Guterriez, David Bartrés-Faz, Pierre Payoux, PharmacogConsortium
OHBM (Organization for Human Brain Mapping) - GENEVE.
> Plateau Technique innovant de Radiochimie et de Radiopharmacie du Fluor 18 : Projet Pi-R²
Salabert A-S, Méligne D, Gros-Dagnac H, Alonso M, Tafani M, Payoux P
8ème journées ITS - MARSEILLE

Publications rédigées ou co-rédigées

> 64- Description of a European memory clinic cohort undergoing amyloid-PET: The AMYPAD Diagnostic and Patient Management Study.
Altomare D, Collij L, Caprioglio C, Scheltens P, van Berckel BNM, Alves IL, Berkhof J, de Gier Y, Garibotto V, Moro C, Poitrine L, Delrieu J, Payoux P, Saint-Aubert L, Molinuevo JL, Grau-Rivera O, Gispert JD, Minguillón C, Fauria K, Sanchez MF, Rădoi A, Drzezga A, Jessen F, Escher C, Zeyen P, Nordberg A, Savitcheva I, Jelic V, Walker Z, Lee HY, Lee L, Demonet JF, Plaza Wuthrich S, Gismondi R, Farrar G, Barkhof F, Stephens AW, Frisoni GB; AMYPAD Consortium.
Alzheimers Dement. 2023 Mar;19(3):844-856. doi: 10.1002/alz.12696.
> 62- Alzheimer’s disease genetic pathways impact cerebrospinal fluid biomarkers and imaging endophenotypes in non-demented individuals.
Lorenzini L, Collij LE, Tesi N, Vilor-Tejedor N, Ingala S, Blennow K, Foley C, Frisoni GB, Haller S, Holstege H, van der van der Lee S, Martinez-Lage P, Marioni RE, McCartney DL, O’ Brien J, Oliveira TG, Payoux P, Reinders M, Ritchie C, Scheltens P, Schwarz AJ, Sudre CH, Waldman AD, Wolz R, Chatelat G, Ewers M, Wink AM, Mutsaerts HJMM, Gispert JD, Visser PJ, Tijms BM, Altmann A, Barkhof F.
Alzheimers Dement. 2024 Jul 29. doi: 10.1002/alz.14096.
> 60- Adaptive Strategies of Single-Sided Deaf Cochlear-Implant Users Revealed Through Resting State Activity: an Auditory PET Brain Imaging Study.
Strelnikov K, Karoui C, Payoux P, Salabert AS, James C, Deguine O, Barone P, Marx M.
Hear Res. 2024 Jul 11;451:109079. doi: 10.1016/j.heares.2024.109079.
> 52- Alzheimer’s Disease and Small Vessel Disease Differentially Affect White Matter Microstructure.
Tranfa M, Lorenzini L, Collij LE, Vállez García D, Ingala S, Pontillo G, Pieperhoff L, Maranzano A, Wolz R, Haller S, Blennow K, Frisoni G, Sudre CH, Chételat G, Ewers M, Payoux P, Waldman A, Martinez-Lage P, Schwarz AJ, Ritchie CW, Wardlaw JM, Gispert JD, Brunetti A, Mutsaerts HJMM, Wink AM, Barkhof F.
Ann Clin Transl Neurol. 2024 Jun;11(6):1541-1556. doi: 10.1002/acn3.52071.
> 51- PET Study of Microglial Activation in Kleine-Levin Syndrome.
Barateau L, Krache A, Da Costa A, Lecendreux M, Chenini S, Arlicot N, Vourc’h P, Alonso M, Salabert AS, Beziat S, Jaussent I, Mariano-Goulart D, Payoux P, Dauvilliers Y.
Neurol Neuroimmunol Neuroinflamm. 2024 Jul;11(4):e200263. doi: 10.1212/NXI.0000000000200263. https://pubmed.ncbi.nlm.nih.gov/38885456/
> 49- Translocator protein (TSPO) genotype does not change cerebrospinal fluid levels of glial activation, axonal and synaptic damage markers in early Alzheimer’s disease.
Gouilly D, Vrillon A, Bertrand E, Goubeaud M, Catala H, Germain J, Ainaoui N, Rafiq M, Nogueira L, Mouton-Liger F, Planton M, Salabert AS, Hitzel A, Méligne D, Jasse L, Sarton B, Silva S, Lemesle B, Péran P, Payoux P, Thalamas C, Paquet C, Pariente J.
Neuroimage Clin. 2024 May 31;43:103626. doi: 10.1016/j.nicl.2024.103626.
> 42-Alzheimer’s Disease and Small Vessel Disease Differentially Affect White Matter Microstructure.
Tranfa M, Lorenzini L, Collij LE, Vállez García D, Ingala S, Pontillo G, Pieperhoff L, Maranzano A, Wolz R, Haller S, Blennow K, Frisoni G, Sudre CH, Chételat G, Ewers M, Payoux P, Waldman A, Martinez-Lage P, Schwarz AJ, Ritchie CW, Wardlaw JM, Gispert JD, Brunetti A, Mutsaerts HJMM, Wink AM, Barkhof F.
Ann Clin Transl Neurol. 2024 May 16. doi: 10.1002/acn3.52071.
> 32- Microglia Density and Its Association With Disease Duration, Severity, and Orexin Levels in Patients With Narcolepsy Type 1
Barateau L, Krache A, Da Costa A, Lecendreux M, Debs R, Chenini S, Arlicot N, Vourc’h P, Evangelista E, Alonso M, Salabert AS, Silva S, Béziat S, Jaussent I, Mariano-Goulart D, Payoux P, Dauvilliers Y.
Neurology. 2024 May;102(10):e209326. doi: 10.1212/WNL.0000000000209326.
> 27- Investigating reliable amyloid accumulation in Centiloids: Results from the AMYPAD Prognostic and Natural History Study.
Bollack A, Collij LE, García DV, Shekari M, Altomare D, Payoux P, Dubois B, Grau-Rivera O, Boada M, Marquié M, Nordberg A, Walker Z, Scheltens P, Schöll M, Wolz R, Schott JM, Gismondi R, Stephens A, Buckley C, Frisoni GB, Hanseeuw B, Visser PJ, Vandenberghe R, Drzezga A, Yaqub M, Boellaard R, Gispert JD, Markiewicz P, Cash DM, Farrar G, Barkhof F; AMYPAD consortium.
Alzheimers Dement. 2024 Apr 4. doi: 10.1002/alz.13761.
> 23- The Optic Nerve at Stake: Update on Environmental Factors Modulating Expression of Leber’s Hereditary Optic Neuropathy.
Layrolle P, Orssaud C, Leleu M, Payoux P, Chavanas S.
Biomedicines. 2024 Mar 6;12(3):584. doi: 10.3390/biomedicines12030584.
> 16- Neuroimmune activation is associated with neurological outcome in anoxic and traumatic coma.
Sarton B, Tauber C, Fridman E, Péran P, Riu B, Vinour H, David A, Geeraerts T, Bounes F, Minville V, Delmas C, Salabert AS, Albucher JF, Bataille B, Olivot JM, Cariou A, Naccache L, Payoux P, Schiff N, Silva S.
Brain. 2024 Feb 27:awae045. doi: 10.1093/brain/awae045.
> 14- Association Between Years of Education and Amyloid Burden in Patients With Subjective Cognitive Decline, MCI, and Alzheimer Disease.
Hönig M, Altomare D, Caprioglio C, Collij L, Barkhof F, Van Berckel B, Scheltens P, Farrar G, Battle MR, Theis H, Giehl K, Bischof GN, Garibotto V, Molinuevo JLL, Grau-Rivera O, Delrieu J, Payoux P, Demonet JF, Nordberg AK, Savitcheva I, Walker Z, Edison P, Stephens AW, Gismondi R, Jessen F, Buckley CJ, Gispert JD, Frisoni GB, Drzezga A; AMYPAD Consortium.
Neurology. 2024 Mar 26;102(6):e208053. doi: 10.1212/WNL.0000000000208053.
> 76- Associations between blood nutritional biomarkers and cerebral Amyloid-β: Insights from the COGFRAIL Cohort Study.
de França NAG, Díaz G, Lengelé L, Soriano G, Caspar-Bauguil S, Saint-Aubert L, Payoux P, Rouch L, Vellas B, Barreto PS, Sourdet S.
J Gerontol A Biol Sci Med Sci. 2023 Oct 25:glad248. doi: 10.1093/gerona/glad248.
> 73- Changes of cerebral functional connectivity induced by foot reflexology in a RCT.
Descamps E, Boussac M, Joineau K, Payoux P.
Sci Rep. 2023 Oct 10;13(1):17139. doi: 10.1038/s41598-023-44325-x. PMID: 37816799 Free PMC article. Clinical Trial.
> 59- Clinical heterogeneity of neuro-inflammatory PET profiles in early Alzheimer’s disease.
Gouilly D, Salabert AS, Bertrand E, Goubeaud M, Catala H, Germain J, Ainaoui N, Rafiq M, Benaiteau M, Carlier J, Nogueira L, Planton M, Hitzel A, Méligne D, Sarton B, Silva S, Lemesle B, Payoux P, Thalamas C, Péran P, Pariente J.
Front Neurol. 2023 Jul 31;14:1189278. doi: 10.3389/fneur.2023.1189278.
> 37- Clinical Effect of Early vs Late Amyloid Positron Emission Tomography in Memory Clinic Patients: The AMYPAD-DPMS Randomized Clinical Trial.
Altomare D, Barkhof F, Caprioglio C, Collij LE, Scheltens P, Lopes Alves I, Bouwman F, Berkhof J, van Maurik IS, Garibotto V, Moro C, Delrieu J, Payoux P, Saint-Aubert L, Hitzel A, Molinuevo JL, Grau-Rivera O, Gispert JD, Drzezga A, Jessen F, Zeyen P, Nordberg A, Savitcheva I, Jelic V, Walker Z, Edison P, Demonet JF, Gismondi R, Farrar G, Stephens AW, Frisoni GB; Amyloid Imaging to Prevent Alzheimer’s Disease (AMYPAD) Consortium.
JAMA Neurol. 2023 Jun 1;80(6):548-557. doi: 10.1001/jamaneurol.2023.0997.
> 29- Eigenvector centrality dynamics are related to Alzheimer’s disease pathological changes in non-demented individuals.
Lorenzini L, Ingala S, Collij LE, Wottschel V, Haller S, Blennow K, Frisoni G, Chételat G, Payoux P, Lage-Martinez P, Ewers M, Waldman A, Wardlaw J, Ritchie C, Gispert JD, Mutsaerts HJMM, Visser PJ, Scheltens P, Tijms B, Barkhof F, Wink AM.
Brain Commun. 2023 Mar 28;5(3):fcad088. doi: 10.1093/braincomms/fcad088.
> 28- Clinical Effect of Early vs Late Amyloid Positron Emission Tomography in Memory Clinic Patients: The AMYPAD-DPMS Randomized Clinical Trial.
Altomare D, Barkhof F, Caprioglio C, Collij LE, Scheltens P, Lopes Alves I, Bouwman F, Berkhof J, van Maurik IS, Garibotto V, Moro C, Delrieu J, Payoux P, Saint-Aubert L, Hitzel A, Molinuevo JL, Grau-Rivera O, Gispert JD, Drzezga A, Jessen F, Zeyen P, Nordberg A, Savitcheva I, Jelic V, Walker Z, Edison P, Demonet JF, Gismondi R, Farrar G, Stephens AW, Frisoni GB; Amyloid Imaging to Prevent Alzheimer’s Disease (AMYPAD) Consortium.
JAMA Neurol. 2023 May 8. doi: 10.1001/jamaneurol.2023.0997.
> 13- Pharmacological Characterization of [18F]-FNM and Evaluation of NMDA Receptors Activation in a Rat Brain Injury Model.
Beaurain M, Talmont F, Pierre D, Péran P, Boucher S, Hitzel A, Rols MP, Cuvillier O, Payoux P, Salabert AS.
Mol Imaging Biol. 2023 Mar 21. doi: 10.1007/s11307-023-01811-y.
> 12- Beyond the amyloid cascade: An update of Alzheimer’s disease pathophysiology
Gouilly D, Rafiq M, Nogueira L, Salabert AS, Payoux P, Péran P, Pariente J.
Rev Neurol (Paris). 2023 Mar 9:S0035-3787(23)00870-6. doi: 10.1016/j.neurol.2022.12.006.
> 11- Auditory cortical plasticity after cochlear implantation in asymmetric hearing loss is related to spatial hearing: a PET H215O study.
Karoui C, Strelnikov K, Payoux P, Salabert AS, James CJ, Deguine O, Barone P, Marx M.
Cereb Cortex. 2023 Feb 20;33(5):2229-2244. doi: 10.1093/cercor/bhac204.
> 10- Abnormal brain function in photophobic patients with dry eye disease: An fMRI study.
Tazi S, Boulanouar AK, Cassagne M, Fournié P, Malecaze J, Payoux P, Malecaze F, Cohen L.
Rev Neurol (Paris). 2023 Feb 28:S0035-3787(23)00822-6. doi: 10.1016/j.neurol.2022.11.014.
> 89- Gray matter network properties show distinct associations with CSF p-tau 181 levels and amyloid status in individuals without dementia.
Luigi L, Silvia I, Viktor W, Wink AM, Mutsaerts HJ, Sven H, Kaj B, O’Brien JT, Giovanni FB, Gael C, Pierre Payoux, Pablo ML, Adam W, Joanna W, Craig R, Gispert JD, Visser PJ, Philip S, Frederik B, Tijms BM.
Aging Brain. 2022 Oct 23;2:100054. doi: 10.1016/j.nbas.2022.100054.
> 87- Message in a Scaffold: Natural Biomaterials for Three-Dimensional (3D) Bioprinting of Human Brain Organoids.
Layrolle P, Payoux P, Chavanas S.
Biomolecules. 2022 Dec 22;13(1):25. doi: 10.3390/biom13010025.
> 57- The Open-Access European Prevention of Alzheimer’s Dementia (EPAD) MRI dataset and processing workflow.
Lorenzini L, Ingala S, Wink AM, Kuijer JPA, Wottschel V, Dijsselhof M, Sudre CH, Haller S, Molinuevo JL, Gispert JD, Cash DM, Thomas DL, Vos SB, Prados F, Petr J, Wolz R, Palombit A, Schwarz AJ, Chételat G, Payoux P, Di Perri C, Wardlaw JM, Frisoni GB, Foley C, Fox NC, Ritchie C, Pernet C, Waldman A, Barkhof F, Mutsaerts HJMM; EPAD consortium.
Neuroimage Clin. 2022;35:103106. doi: 10.1016/j.nicl.2022.103106.
> 40- Description of a European memory clinic cohort undergoing amyloid-PET: The AMYPAD Diagnostic and Patient Management Study.
Altomare D, Collij L, Caprioglio C, Scheltens P, van Berckel BNM, Alves IL, Berkhof J, de Gier Y, Garibotto V, Moro C, Poitrine L, Delrieu J, Payoux P, Saint-Aubert L, Molinuevo JL, Grau-Rivera O, Gispert JD, Minguillón C, Fauria K, Sanchez MF, Rădoi A, Drzezga A, Jessen F, Escher C, Zeyen P, Nordberg A, Savitcheva I, Jelic V, Walker Z, Lee HY, Lee L, Demonet JF, Plaza Wuthrich S, Gismondi R, Farrar G, Barkhof F, Stephens AW, Frisoni GB; AMYPAD Consortium.
Alzheimers Dement. 2022 Jun 17. doi: 10.1002/alz.12696.
> 28- Functional Imaging for Neurodegenerative Diseases.
Chollet F, Payoux P.
Presse Med. 2022 Apr 28:104121. doi: 10.1016/j.lpm.2022.104121.
> 9- Preclinical Pharmacokinetics and Dosimetry of an 89Zr Labelled Anti-PDL1 in an Orthotopic Lung Cancer Murine Model.
Krache A, Fontan C, Pestourie C, Bardiès M, Bouvet Y, Payoux P, Chatelut E, White-Koning M, Salabert AS.
Front Med (Lausanne). 2022 Jan 31;8:741855. doi: 10.3389/fmed.2021.741855.
> 4- Neuroinflammation PET imaging of the translocator protein (TSPO) in Alzheimer’s disease: an update.
Gouilly D, Saint-Aubert L, Ribeiro MJ, Salabert AS, Tauber C, Péran P, Arlicot N, Pariente J, Payoux P.
Eur J Neurosci. 2022 Jan 26. doi: 10.1111/ejn.15613.
> 2- PET metabolic tumor volume as a new prognostic factor in childhood rhabdomyosarcoma.
Fayolle H, Jehanno N, Lauwers-Cances V, Castex MP, Orbach D, Mognetti T, Nadège C, Payoux P, Hitzel A.
PLoS One. 2022 Jan 14;17(1):e0261565. doi: 10.1371/journal.pone.0261565.
> 84- Reduced Regional Cerebral Blood Flow Measured by 99mTc-Hexamethyl Propylene Amine Oxime Single-Photon Emission Computed Tomography in Microgravity Simulated by 5-Day Dry Immersion.
Guillon L, Kermorgant M, Charvolin T, Bonneville F, Bareille MP, Cassol E, Beck A, Beaurain M, Péran P, Lotterie JA, Traon AP, Payoux P.
Front Physiol. 2021 Nov 22;12:789298. doi: 10.3389/fphys.2021.789298.
> 57- PPAR Gamma and Viral Infections of the Brain
Pierre Layrolle, Pierre Payoux, and Stéphane Chavanas
Int J Mol Sci. 2021 Aug; 22(16): 8876 doi: 10.3390/ijms22168876
> 48- Functional connectivity and cognitive changes after donepezil treatment in healthy participants.
Péran P, Salabert AS, Dondaine T, Leclerc X, Gros-Dagnac H, Ranjeva JP, Lopes R, Lanteaume L, Blin O, Thalamas C, Bordet R, Payoux P; PharmaCog Consortium.
Psychopharmacology (Berl). 2021 Aug 9. doi: 10.1007/s00213-021-05923-7.
> 14- Contributions of PET and MRI imaging in the evaluation of CNS drugs in human neurodegenerative diseases.
Payoux P, Ranjeva JP.
<a
Voir la publication
Therapie. 2020 Dec 5:S0040-5957(20)30225-0. doi: 10.1016/j.therap.2020.12.008.
> 43- Modular slowing of resting-state dynamic Functional Connectivity as a marker of cognitive dysfunction induced by sleep deprivation.
Lombardo D, Cassé-Perrot C, Ranjeva JP, Le Troter A, Guye M, Wirsich J, Payoux P, Bartrés-Faz D, Bordet R, Richardson JC, Felician O, Jirsa V, Blin O, Didic M, Battaglia D.
Voir la publication
Neuroimage. 2020 Jul 28:117155. doi: 10.1016/j.neuroimage.2020.117155. Online ahead of print.
> 39- Editorial: Nuclear Medicine in the Context of Personalized Medicine.
Barbet J, Bernaudin M, Payoux P, Cicone F, Gaugler MH, Kraeber-Bodéré F.
Voir la publication
Front Med (Lausanne). 2020 Jun 9;7:252. doi: 10.3389/fmed.2020.00252.
> 29- Amygdalar nuclei and hippocampal subfields on MRI: test-retest reliability of automated volumetry across different MRI sites and vendors.
Quattrini G, Pievani M, Jovicich J, Aiello M, Bargalló N, Barkhof F, Bartres-Faz D, Beltramello A, Pizzini FB, Blin O, Bordet R, Caulo M, Constantinides M, Didic M, Drevelegas A, Ferretti A, Fiedler U, Floridi P, Gros-Dagnac H, Hensch T, Hoffmann KT, Kuijer JP, Lopes R, Marra C, Müller BW, Nobili F, Parnetti L, Payoux P, Picco A, Ranjeva JP, Roccatagliata L, Rossini PM, Salvatore M, Schonknecht P, Schott BH, Sein J, Soricelli A, Tarducci R, Tsolaki M, Visser PJ, Wiltfang J, Richardson JC, Frisoni GB, Marizzoni M; PharmaCog Consortium.
Voir la publication
Neuroimage. 2020 May 13:116932. doi: 10.1016/j.neuroimage.2020.116932.
> 26- Interhemispheric distribution of amyloid and small vessel disease burden in cerebral amyloid angiopathy-related intracerebral hemorrhage.
Planton M, Pariente J, Nemmi F, Albucher JF, Calviere L, Viguier A, Olivot JM, Salabert AS, Payoux P, Peran P, Raposo N.
Voir la publication
Eur J Neurol. 2020 May 11. doi: 10.1111/ene.14301.
> 24- An Alzheimer Disease Challenge Model: 24-Hour Sleep Deprivation in Healthy Volunteers, Impact on Working Memory, and Reversal Effect of Pharmacological Intervention: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study.
Chan Kwong A, Cassé-Perrot C, Costes-Salon MC, Jouve E, Lanteaume L, Audebert C, Rouby F, Lefebvre MN, Ranjeva JP, Beck A, Deplanque D, Ponchel A, Vervueren C, Truillet R, Babilon C, Auffret A, Richardson JC, Payoux P, Bartrés-Faz D, Blin O, Bordet R, Micallef J; Pharmacog Consortium.
Voir la publication
J Clin Psychopharmacol. 2020 May/Jun;40(3):222-230. doi: 10.1097/JCP.0000000000001199.
> 21- Quantitative amyloid PET in Alzheimer’s disease: the AMYPAD prognostic and natural history study.
Lopes Alves I, Collij LE, Altomare D, Frisoni GB, Saint-Aubert L, Payoux P, Kivipelto M, Jessen F, Drzezga A, Leeuwis A, Wink AM, Visser PJ, van Berckel BNM, Scheltens P, Gray KR, Wolz R, Stephens A, Gismondi R, Buckely C, Gispert JD, Schmidt M, Ford L, Ritchie C, Farrar G, Barkhof F, Molinuevo JL; AMYPAD Consortium.
Voir la publication
Alzheimers Dement. 2020 Apr 12. doi: 10.1002/alz.12069.
> 7- CSF cutoffs for MCI due to AD depend on APOEε4 carrier status.
Marizzoni M, Ferrari C, Babiloni C, Albani D, Barkhof F, Cavaliere L, Didic M, Forloni G, Fusco F, Galluzzi S, Hensch T, Jovicich J, Marra C, Molinuevo JL, Nobili F, Parnetti L, Payoux P, Ranjeva JP, Ribaldi F, Rolandi E, Rossini PM, Salvatore M, Soricelli A, Tsolaki M, Visser PJ, Wiltfang J, Richardson JC, Bordet R, Blin O, Frisoni GB.
Voir la publication
Neurobiol Aging. 2019 Dec 30. pii: S0197-4580(19)30448-8. doi: 10.1016/j.neurobiolaging.2019.12.019.
> 5- Biomechanical response of the CNS is associated with frailty in NPH-suspected patients.
Vallet A, Del Campo N, Hoogendijk EO, Lokossou A, Balédent O, Czosnyka Z, Balardy L, Payoux P, Swider P, Lorthois S, Schmidt E.
Voir la publication
J Neurol. 2020 Jan 29. doi: 10.1007/s00415-019-09689-z.
> 2- Amyloid-β transmission through cardiac surgery using cadaveric dura mater patch.
Raposo N, Planton M, Siegfried A, Calviere L, Payoux P, Albucher JF, Viguier A, Delisle MB, Uro-Coste E, Chollet F, Bonneville F, Olivot JM, Pariente J.
Voir la publication
J Neurol Neurosurg Psychiatry. 2020 Jan 20. pii: jnnp-2019-321927. doi: 10.1136/jnnp-2019-321927.
> 1- Florbetapir Regional Distribution in Cerebral Amyloid Angiopathy and Alzheimer’s Disease: A PET Study.
Planton M, Saint-Aubert L, Raposo N, Payoux P, Salabert AS, Albucher JF, Olivot JM, Péran P, Pariente J.
Voir la publication
J Alzheimers Dis. 2020 Jan 13. doi: 10.3233/JAD-190625.
> 56- Accuracy and reproducibility of automated white matter hyperintensities segmentation with lesion segmentation tool: A European multi-site 3T study.
Ribaldi F, Altomare D, Jovicich J, Ferrari C, Picco A, Pizzini FB, Soricelli A, Mega A, Ferretti A, Drevelegas A, Bosch B, Müller BW, Marra C, Cavaliere C, Bartrés-Faz D, Nobili F, Alessandrini F, Barkhof F, Gros-Dagnac H, Ranjeva JP, Wiltfang J, Kuijer J, Sein J, Hoffmann KT, Roccatagliata L, Parnetti L, Tsolaki M, Constantinidis M, Aiello M, Salvatore M, Montalti M, Caulo M, Didic M, Bargallo N, Blin O, Rossini P, Schonknecht P, Floridi P, Payoux P, Visser PJ, Bordet R, Lopes R, Tarducci R, Bombois S, Hensch T, Fiedler U, Richardson JC, Frisoni GB, Marizzoni M.
Voir la publication
Magn Reson Imaging. 2020 Nov 18:S0730-725X(20)30643-3. doi: 10.1016/j.mri.2020.11.008.
> 49- CSF cutoffs for MCI due to AD depend on APOEε4 carrier status
Marizzoni M, Ferrari C, Babiloni C, Albani D, Barkhof F, Cavaliere L, Didic M, Forloni G, Fusco F, Galluzzi S, Hensch T, Jovicich J, Marra C, Molinuevo JL, Nobili F, Parnetti L, Payoux P, Ranjeva JP, Ribaldi F, Rolandi E, Rossini PM, Salvatore M, Soricelli A, Tsolaki M, Visser PJ, Wiltfang J, Richardson JC, Bordet R, Blin O, Frisoni GB.
Voir la publication
Neurobiol Aging. 2020 May;89:55-62. doi: 10.1016/j.neurobiolaging.2019.12.019. Epub 2019 Dec 30. PMID: 32029236
> 47- Benzodiazepine use and brain amyloid load in nondemented older individuals: a florbetapir PET study in the Multidomain Alzheimer Preventive Trial cohort
Desmidt T, Delrieu J, Lebouvier T, Robert G, David R, Balageas AC, Surget A, Belzung C, Arlicot N, Ribeiro MJ, Payoux P, Vellas B, El-Hage W, Tavernier E, Camus V; MAPT/DSA study group.
Neurobiol Aging. 2019 Aug 14;84:61-69. doi: 10.1016/j.neurobiolaging.2019.08.008. Voir la publication
> 42- Enlarged perivascular spaces and florbetapir uptake in patients with intracerebral hemorrhage.
Raposo N, Planton M, Payoux P, Péran P, Albucher JF, Calviere L, Viguier A, Rousseau V, Hitzel A, Chollet F, Olivot JM, Bonneville F, Pariente J.
Voir la publication
Eur J Nucl Med Mol Imaging. 2019 Jul 29. doi: 10.1007/s00259-019-04441-1.
> 31- The use of labelled leucocyte scintigraphy to evaluate chronic periprosthetic joint infections: a retrospective multicentre study on 168 patients.
Blanc P, Bonnet E, Giordano G, Monteil J, Salabert AS, Payoux P.
Eur J Clin Microbiol Infect Dis. 2019 Jun 20. doi: 10.1007/s10096-019-03587-y.
> 38- Cognitive changes of older adults with an equivocal amyloid load.
Pothier K, Saint-Aubert L, Hooper C, Delrieu J, Payoux P, de Souto Barreto P, Vellas B; MAPT/DSA Study Group.
Voir la publication
J Neurol. 2019 Apr;266(4):835-843. doi: 10.1007/s00415-019-09203-5. Epub 2019 Jan 28.
> 63- Dopamine transporter imaging for the diagnosis of multiple system atrophy cerebellar type.
Vergnet S, Hives F, Foubert-Samier A, Payoux P, Fernandez P, Meyer M, Dupouy J, Brefel-Courbon C, Ory-Magne F, Rascol O, Tison F, Pavy-Le Traon A, Meissner WG.
Voir la publication
Parkinsonism Relat Disord. 2019 Jun;63:199-203. doi: 10.1016/j.parkreldis.2019.02.006. Epub 2019 Feb 5.
> 16- Biomarker Matrix to Track Short Term Disease Progression in Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer’s Disease.
Marizzoni M, Ferrari C, Macis A, Jovicich J, Albani D, Babiloni C, Cavaliere L, Didic M, Forloni G, Galluzzi S, Hoffmann KT, Molinuevo JL, Nobili F, Parnetti L, Payoux P, Pizzini F, Rossini PM, Salvatore M, Schönknecht P, Soricelli A, Del Percio C, Hensch T, Hegerl U, Tsolaki M, Visser PJ, Wiltfang J, Richardson JC, Bordet R, Blin O, Frisoni GB; PharmaCog Consortium.
J Alzheimers Dis. 2019 Apr 1. doi: 10.3233/JAD-181016.
> 60- Innovative Molecular Imaging for Clinical Research, Therapeutic Stratification, and Nosography in Neuroscience.
Beaurain M, Salabert AS, Ribeiro MJ, Arlicot N, Damier P, Le Jeune F, Demonet JF, Payoux P.
Voir la publication
Front Med (Lausanne). 2019 Nov 27;6:268. doi: 10.3389/fmed.2019.00268. eCollection 2019. Review.
> 12- Functional connectivity of hypothalamus in chronic migraine with medication overuse.
Lerebours F, Boulanouar K, Barège M, Denuelle M, Bonneville F, Payoux P, Larrue V, Fabre N.
Cephalalgia. 2019 Mar 5:333102419833087. doi: 10.1177/0333102419833087.
> 6- Dopaminergic denervation using [123I]-FPCIT and pain in Parkinson’s disease: a correlation study.
Dellapina E, Pellaprat J, Adel D, Llido J, Harroch E, Martini JB, Kas A, Salabert AS, Ory-Magne F, Payoux P, Brefel-Courbon C.
J Neural Transm (Vienna). 2019 Jan 31. doi: 10.1007/s00702-019-01974-5.
> 4- Cognitive changes of older adults with an equivocal amyloid load.
Pothier K, Saint-Aubert L, Hooper C, Delrieu J, Payoux P, de Souto Barreto P, Vellas B; MAPT/DSA Study Group.
J Neurol. 2019 Jan 28. doi: 10.1007/s00415-019-09203-5.
> 2- Association between brain -amyloid and frailty in older adults.
Maltais M, de Souto Barreto P, Hooper C, Payoux P, Rolland Y, Vellas B; MAPT/DSA Study Group.
J Gerontol A Biol Sci Med Sci. 2019 Jan 9. doi: 10.1093/gerona/glz009.
> 52- Two-Year Longitudinal Monitoring of Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer’s Disease Using Topographical Biomarkers Derived from Functional Magnetic Resonance Imaging and Electroencephalographic Activity.
Jovicich J, Babiloni C, Ferrari C, Marizzoni M, Moretti DV, Del Percio C, Lizio R, Lopez S, Galluzzi S, Albani D, Cavaliere L, Minati L, Didic M, Fiedler U, Forloni G, Hensch T, Molinuevo JL, Bartrés Faz D, Nobili F, Orlandi D, Parnetti L, Farotti L, Costa C, Payoux P, Rossini PM, Marra C, Schönknecht P, Soricelli A, Noce G, Salvatore M, Tsolaki M, Visser PJ, Richardson JC, Wiltfang J, Bordet R, Blin O, Frisoniand GB.
J Alzheimers Dis. 2018 Oct 29. doi: 10.3233/JAD-180158.
> 50- AMYPAD Diagnostic and Patient Management Study: Rationale and design.
Frisoni GB, Barkhof F, Altomare D, Berkhof J, Boccardi M, Canzoneri E, Collij L, Drzezga A, Farrar G, Garibotto V, Gismondi R, Gispert JD, Jessen F, Kivipelto M, Alves IL, Molinuevo JL, Nordberg A, Payoux P, Ritchie C, Savicheva I, Scheltens P, Schmidt ME, Schott J, Stephens A, van Berckel B, Vellas B, Walker Z, Raffa N.
Alzheimers Dement. 2018 Oct 16. pii: S1552-5260(18)33528-3. doi: 10.1016/j.jalz.2018.09.003.
> 41- Plasma Aβ42 as Biomarker of Prodromal Alzheimer’s Disease Progression in Patients with Amnestic Mild Cognitive Impairment: Evidence from the PharmaCog/E-ADNI Study.
Albani D, Marizzoni M, Ferrari C, Fusco F, Boeri L, Raimondi I, Jovicich J, Babiloni C, Soricelli A, Lizio R, Galluzzi S, Cavaliere L, Didic M, Schönknecht P, Molinuevo JL, Nobili F, Parnetti L, Payoux P, Bocchio L, Salvatore M, Rossini PM, Tsolaki M, Visser PJ, Richardson JC, Wiltfang J, Bordet R, Blin O, Forloni G, Frisoni GB, Consortium P.
J Alzheimers Dis. 2018 Aug 20. doi: 10.3233/JAD-180321.
> 38- Assessment of Translocator Protein Density, as Marker of Neuroinflammation, in Major Depressive Disorder: A Pilot, Multicenter, Comparative, Controlled, Brain PET Study (INFLADEP Study).
Yrondi A, Aouizerate B, El-Hage W, Moliere F, Thalamas C, Delcourt N, Sporer M, Taib S, Schmitt L, Arlicot N, Meligne D, Sommet A, Salabert AS, Guillaume S, Courtet P, Galtier F, Mariano-Goulart D, Champfleur NM, Bars EL, Desmidt T, Lemaire M, Camus V, Santiago-Ribeiro MJ, Cottier JP, Fernandez P, Meyer M, Dousset V, Doumy O, Delhaye D, Capuron L, Leboyer M, Haffen E, Péran P, Payoux P, Arbus C.
Front Psychiatry. 2018 Jul 24;9:326. doi: 10.3389/fpsyt.2018.00326. eCollection 2018.
> 37- Involvement of the Cingulate Cortex in Anosognosia: A Multimodal Neuroimaging Study in Alzheimer’s Disease Patients.
Guerrier L, Men JL, Gane A, Planton M, Salabert AS, Payoux P, Dumas H, Bonneville F, Péran P, Pariente J.
J Alzheimers Dis. 2018 Jul 20. doi: 10.3233/JAD-180324.
> 30- Predicting and Tracking Short Term Disease Progression in Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer’s Disease: Structural Brain Biomarkers.
Marizzoni M, Ferrari C, Jovicich J, Albani D, Babiloni C, Cavaliere L, Didic M, Forloni G, Galluzzi S, Hoffmann KT, Molinuevo JL, Nobili F, Parnetti L,Payoux P, Ribaldi F, Rossini PM, Schönknecht P, Soricelli A, Hensch T, Tsolaki M, Visser PJ, Wiltfang J, Richardson JC, Bordet R, Blin O, Frisoni GB; PharmaCog Consortium.
J Alzheimers Dis. 2018 Jun 9. doi: 10.3233/JAD-180152.
> 12- Value of PET/CT 3D visualization of head and neck squamous cell carcinoma extended to mandible.
Lopez R, Gantet P, Julian A, Hitzel A, Herbault-Barres B, Alshehri S, Payoux P.
J Craniomaxillofac Surg. 2018 Feb 24. pii: S1010-5182(18)30049-0. doi: 10.1016/j.jcms.2018.02.007.
> 5- MRI supervised and unsupervised classification of Parkinson’s disease and multiple system atrophy.
Péran P, Barbagallo G, Nemmi F, Sierra M, Galitzky M, Traon AP, Payoux P, Meissner WG, Rascol O.
Mov Disord. 2018 Feb 23. doi: 10.1002/mds.27307.
> 7- ICP Monitoring and Phase-Contrast MRI to Investigate Intracranial Compliance.
Lokossou A, Balédent O, Garnotel S, Page G, Balardy L, Czosnyka Z, Payoux P, Schmidt EA.
Acta Neurochir Suppl. 2018;126:247-253. doi: 10.1007/978-3-319-65798-1_50.
> 3- Joint Assessment of Quantitative 18F-Florbetapir and 18F-FDG Regional Uptake Using Baseline Data from the ADNI.
Ben Bouallègue F, Mariano-Goulart D, Payoux P; Alzheimer’s Disease Neuroimaging Initiative (ADNI).
J Alzheimers Dis. 2018;62(1):399-408. doi: 10.3233/JAD-170833.
> 2- Diagnostic and prognostic value of amyloid PET textural and shape features: comparison with classical semi-quantitative rating in 760 patients from the ADNI-2 database.
Ben Bouallègue F, Vauchot F, Mariano-Goulart D, Payoux P.
Brain Imaging Behav. 2018 Feb 9. doi: 10.1007/s11682-018-9833-0.
> 46- New PET markers for the diagnosis of dementia.
Payoux P, Salabert AS.
Curr Opin Neurol. 2017 Dec;30(6):608-616. doi: 10.1097/WCO.0000000000000489.
> 72- Evaluation of [18F]FNM biodistribution and dosimetry based on whole-body PET imaging of rats.
Salabert AS, Mora-Ramirez E, Beaurain M, Alonso M, Fontan C, Tahar HB, Boizeau ML, Tafani M, Bardiès M, Payoux P.
Nucl Med Biol. 2017 Dec 21;59:1-8. doi:10.1016/j.nucmedbio.2017.12.003.
> 71- Enhancing Plasticity of the Central Nervous System: Drugs, Stem Cell Therapy, and Neuro-Implants.
Le Friec A, Salabert AS, Davoust C, Demain B, Vieu C, Vaysse L, Payoux P, Loubinoux I.
Neural Plast. 2017;2017:2545736. doi: 10.1155/2017/2545736. Epub 2017 Dec 17. Review.
> 61- Brain Networks are Independently Modulated by Donepezil, Sleep, and Sleep Deprivation.
Wirsich J, Rey M, Guye M, Bénar C, Lanteaume L, Ridley B, Confort-Gouny S, Cassé-Perrot C, Soulier E, Viout P, Rouby F, Lefebvre MN, Audebert C, Truillet R, Jouve E, Payoux P, Bartrés-Faz D, Bordet R, Richardson JC, Babiloni C, Rossini PM, Micallef J, Blin O, Ranjeva JP; Pharmacog Consortium.
Brain Topogr. 2017 Nov 23. doi: 10.1007/s10548-017-0608-5.
> 60- Cross-sectional Associations of Fatigue with Cerebral β-Amyloid in Older Adults at Risk of Dementia.
Hooper C, De Souto Barreto P, Coley N, Cesari M, Payoux P, Salabert AS, Andrieu S, Vellas B; MAPT/DSA Study Group.
Front Med (Lausanne). 2017 Nov 6;4:173. doi: 10.3389/fmed.2017.00173. eCollection 2017
> 56- Added value of 18F-florbetaben amyloid PET in the diagnostic workup of most complex patients with dementia in France: A naturalistic study.
Ceccaldi M, Jonveaux T, Verger A, Krolak-Salmon P, Houzard C, Godefroy O, Shields T, Perrotin A, Gismondi R, Bullich S, Jovalekic A, Raffa N, Pasquier F, Semah F, Dubois B, Habert MO, Wallon D, Chastan M, Payoux P; NEUUS in AD study group, Stephens A, Guedj E.
Alzheimers Dement. 2017 Oct 26. pii: S1552-5260(17)33763-9. doi: 10.1016/j.jalz.2017.09.009.
> 48- Imaging grafted cells with [18F]FHBG using an optimized HSV1-TK mammalian expression vector in a brain injury rodent model.
Salabert AS, Vaysse L, Beaurain M, Alonso M, Arribarat G, Lotterie JA, Loubinoux I, Tafani M, Payoux P.
PLoS One. 2017 Sep 19;12(9):e0184630. doi: 10.1371/journal.pone.0184630. eCollection 2017.
> 24- Cross-sectional associations of cortical β-amyloid with erythrocyte membrane long-chain polyunsaturated fatty acids in older adults with subjective memory complaints.
Hooper C, De Souto Barreto P, Payoux P, Salabert AS, Guyonnet S, Andrieu S, Vellas B; MAPT/DSA study group..
J Neurochem. 2017 Aug;142(4):589-596. doi: 10.1111/jnc.14062.
> 38- Florbetapir imaging in cerebral amyloid angiopathy-related hemorrhages.
Raposo N, Planton M, Péran P, Payoux P, Bonneville F, Lyoubi A, Albucher JF, Acket B, Salabert AS, Olivot JM, Hitzel A, Chollet F, Pariente J.
Neurology. 2017 Jul 19. pii: 10.1212/WNL.0000000000004228. doi: 10.1212/WNL.0000000000004228.
> 28- Association Between Motor Symptoms and Brain Metabolism in Early Huntington Disease.
Gaura V, Lavisse S, Payoux P, Goldman S, Verny C, Krystkowiak P, Damier P, Supiot F, Bachoud-Levi AC, Remy P.
JAMA Neurol. 2017 Jul 3. doi: 10.1001/jamaneurol.2017.1200.
> 31- Radiosynthesis of [18F]AV1451 in pharmaceutical conditions and its biological characteristics.
Salabert AS, Fontan C, Fonta C, Alonso M, Loukh N, Delisle MB, Tafani M, Payoux P.
Appl Radiat Isot. 2017 Jun 30;128:101-107. doi: 10.1016/j.apradiso.2017.06.032.
> 32- Prospective comparison of 18F-NaF PET/CT versus 18F-FDG PET/CT imaging in mandibular extension of head and neck squamous cell carcinoma with dedicated analysis software and validation with surgical specimen. A preliminary study
Lopez R, Gantet P, Salabert AS, Julian A, Hitzel A, Herbault-Barres B, Fontan C, Alshehri S, Payoux P
Journal of Cranio-Maxillo-Facial Surgery. S1010-5182(17)30225-1 - doi: 10.1016/j.jcms.2017.06.025
> 23- Comparison of CSF markers and semi-quantitative amyloid PET in Alzheimer’s disease diagnosis and in cognitive impairment prognosis using the ADNI-2 database.
Ben Bouallègue F, Mariano-Goulart D, Payoux P; Alzheimer’s Disease Neuroimaging Initiative (ADNI).
Alzheimers Res Ther. 2017 Apr 26;9(1):32. doi: 0.1186/s13195-017-0260-z.
> 69- Comparison of CSF markers and semi-quantitative amyloid PET in Alzheimer’s disease diagnosis and in cognitive impairment prognosis using the ADNI-2 database.
Ben Bouallègue F, Mariano-Goulart D, Payoux P; Alzheimer’s Disease Neuroimaging Initiative (ADNI).
Alzheimers Res Ther. 2017 Apr 26;9(1):32. doi: 10.1186/s13195-017-0260-z.
> 5- Cross-Sectional and Prospective Associations Between β-Amyloid in the Brain and Chair Rise Performance in Nondementia Older Adults With Spontaneous Memory Complaints.
de Souto Barreto P, Cesari M, Rolland Y, Salabert AS, Payoux P, Andrieu S, Vellas B; MAPT Study Group..
J Gerontol A Biol Sci Med Sci. 2017 Feb;72(2):278-283. doi: 10.1093/gerona/glw195. PubMed PMID: 27694343.
> 14- A longitudinal follow-up study of the quantiﬁcation of dopamine transporters with 123I-Ioﬂupane (DaTscan)
H. Fayolle, P. Gantet, A.S. Salabert, J. Delrieu, C. Brefel-Courbon, F. Ory-Magne, T. Voisin, P. Payoux
Médecine Nucléaire 41 (2017) 36-41
> 7- The Use of Oxytocin to Improve Feeding and Social Skills in Infants With Prader-Willi Syndrome.
Tauber M, Boulanouar K, Diene G, Çabal-Berthoumieu S, Ehlinger V, Fichaux-Bourin P, Molinas C, Faye S, Valette M, Pourrinet J, Cessans C, Viaux-Sauvelon S, Bascoul C, Guedeney A, Delhanty P, Geenen V, Martens H, Muscatelli F, Cohen D, Consoli A, Payoux P, Arnaud C, Salles JP.
Pediatrics. 2017 Jan 18. pii: e20162976. doi: 10.1542/peds.2016-2976. PMID: 28100688
> 9- Association between CSF biomarkers, hippocampal volume and cognitive function in patients with amnestic mild cognitive impairment (MCI).
Nathan PJ, Lim YY, Abbott R, Galluzzi S, Marizzoni M, Babiloni C, Albani D, Bartres-Faz D, Didic M, Farotti L, Parnetti L, Salvadori N, Müller BW, Forloni G, Girtler N, Hensch T, Jovicich J, Leeuwis A, Marra C, Molinuevo JL, Nobili F, Pariente J, Payoux P, Ranjeva JP, Rolandi E, Rossini PM, Schönknecht P, Soricelli A, Tsolaki M, Visser PJ, Wiltfang J, Richardson JC, Bordet R, Blin O, Frisoni GB; PharmaCog Consortium.
Neurobiol Aging. 2017 Jan 18;53:1-10. doi: 10.1016/j.neurobiolaging.2017.01.013.
> 2- Free water elimination improves test-retest reproducibility of diffusion tensor imaging indices in the brain: A longitudinal multisite study of healthy elderly subjects.
Albi A, Pasternak O, Minati L, Marizzoni M, Bartrés-Faz D, Bargalló N, Bosch B, Rossini PM, Marra C, Müller B, Fiedler U, Wiltfang J, Roccatagliata L, Picco A, Nobili FM, Blin O, Sein J, Ranjeva JP, Didic M, Bombois S, Lopes R, Bordet R, Gros-Dagnac H, Payoux P, Zoccatelli G, Alessandrini F, Beltramello A, Ferretti A, Caulo M, Aiello M, Cavaliere C, Soricelli A, Parnetti L, Tarducci R, Floridi P, Tsolaki M, Constantinidis M, Drevelegas A, Frisoni G, Jovicich J; PharmaCog Consortium.
Hum Brain Mapp. 2017 Jan;38(1):12-26 doi: 10.1002/hbm.23350.
> 53- Prognostic and predictive values of diffusion and perfusion MRI in paediatric intracranial ependymomas in a large national study.
Tensaouti F, Ducassou A, Chaltiel L, Sevely A, Bolle S, Muracciole X, Coche-Dequant B, Alapetite C, Supiot S, Huchet A, Bernier V, Claude L, Bertozzi-Salamon AI, Liceaga S, Lotterie JA, Péran P, Payoux P, Laprie A; radiotherapy committee of the French Society for Childhood Cancer (SFCE)..
Br J Radiol. 2016 Oct;89(1066):20160537. doi: 10.1259/bjr.20160537.
> 58- Cross-Sectional and Prospective Associations Between β-Amyloid in the Brain and Chair Rise Performance in Nondementia Older Adults With Spontaneous Memory Complaints.
de Souto Barreto P, Cesari M, Rolland Y, Salabert AS, Payoux P, Andrieu S, Vellas B; MAPT Study Group..
J Gerontol A Biol Sci Med Sci. 2016 Sep 30. pii: glw195.
> 43- Clinical and biomarker profiling of prodromal Alzheimer’s disease in workpackage 5 of the Innovative Medicines Initiative PharmaCog project: a ‘European ADNI study’.
Galluzzi S, Marizzoni M, Babiloni C, Albani D, Antelmi L, Bagnoli C, Bartres-Faz D, Cordone S, Didic M, Farotti L, Fiedler U, Forloni G, Girtler N, Hensch T, Jovicich J, Leeuwis A, Marra C, Molinuevo JL, Nobili F, Pariente J, Parnetti L, Payoux P, Del Percio C, Ranjeva JP, Rolandi E, Rossini PM, Schönknecht P, Soricelli A, Tsolaki M, Visser PJ, Wiltfang J, Richardson JC, Bordet R, Blin O, Frisoni GB; PharmaCog Consortium..
J Intern Med. 2016 Jun;279(6):576-91. doi: 10.1111/joim.12482.
> 44- Test-retest reliability of the default mode network in a multi-centric fMRI study of healthy elderly: Effects of data-driven physiological noise correction techniques.
Marchitelli R, Minati L, Marizzoni M, Bosch B, Bartrés-Faz D, Müller BW, Wiltfang J, Fiedler U, Roccatagliata L, Picco A, Nobili F, Blin O, Bombois S, Lopes R, Bordet R, Sein J, Ranjeva JP, Didic M, Gros-Dagnac H, Payoux P, Zoccatelli G, Alessandrini F, Beltramello A, Bargalló N, Ferretti A, Caulo M, Aiello M, Cavaliere C, Soricelli A, Parnetti L, Tarducci R, Floridi P, Tsolaki M, Constantinidis M, Drevelegas A, Rossini PM, Marra C, Schönknecht P, Hensch T, Hoffmann KT, Kuijer JP, Visser PJ, Barkhof F, Frisoni GB, Jovicich J.
Hum Brain Mapp. 2016 Jun;37(6):2114-32. doi: 10.1002/hbm.23157.
> 23- Relationship of regional brain β-amyloid to gait speed.
Del Campo N, Payoux P, Djilali A, Delrieu J, Hoogendijk EO, Rolland Y, Cesari M, Weiner MW, Andrieu S, Vellas B; MAPT/DSA Study Group..
Neurology. 2016 Jan 5;86(1):36-43. doi: 10.1212/WNL.0000000000002235.
> 31- Longitudinal reproducibility of default-mode network connectivity in healthy elderly participants: A multicentric resting-state fMRI study.
Jovicich J, Minati L, Marizzoni M, Marchitelli R, Sala-Llonch R, Bartrés-Faz D, Arnold J, Benninghoff J, Fiedler U, Roccatagliata L, Picco A, Nobili F, Blin O, Bombois S, Lopes R, Bordet R, Sein J, Ranjeva JP, Didic M, Gros-Dagnac H, Payoux P, Zoccatelli G, Alessandrini F, Beltramello A, Bargalló N, Ferretti A, Caulo M, Aiello M, Cavaliere C, Soricelli A, Parnetti L, Tarducci R, Floridi P, Tsolaki M, Constantinidis M, Drevelegas A, Rossini PM, Marra C, Schönknecht P, Hensch T, Hoffmann KT, Kuijer JP, Visser PJ, Barkhof F, Frisoni GB; PharmaCog Consortium..
Neuroimage. 2016 Jan 1;124(Pt A):442-54. doi:10.1016/j.neuroimage.2015.07.010.
> A 15-day course of donepezil modulates spectral EEG dynamics related to target auditory stimuli in young, healthy adult volunteers.
Leroy C, Bourriez JL, Dujardin K, Molaee-Ardekani B, Babiloni C, Deplanque D, Ponchel A, Hennion S, Plomhause L, Devanne H, Deguil J, Payoux P, Blin O, Méligne D, Micallef J, Chauveau N, Lanteaume L, Vervueren C, Guimont F, Thalamas C, Cassé-Perrot C, Rouby F, Bordet R, Derambure P; PharmaCog Consortium..
Clin Neurophysiol. 2015 Nov 27. pii: S1388-2457(15)01119-0. doi: 10.1016/j.clinph.2015.11.018.
> Longitudinal reproducibility of automatically segmented hippocampal subfields: A multisite European 3T study on healthy elderly.
Marizzoni M, Antelmi L, Bosch B, Bartrés-Faz D, Müller BW, Wiltfang J, Fiedler U, Roccatagliata L, Picco A, Nobili F, Blin O, Bombois S, Lopes R, Sein J, Ranjeva JP, Didic M, Gros-Dagnac H, Payoux P, Zoccatelli G, Alessandrini F, Beltramello A, Bargalló N, Ferretti A, Caulo M, Aiello M, Cavaliere C, Soricelli A, Salvadori N, Parnetti L, Tarducci R, Floridi P, Tsolaki M, Constantinidis M, Drevelegas A, Rossini PM, Marra C, Hoffmann KT, Hensch T, Schönknecht P, Kuijer JP, Visser PJ, Barkhof F, Bordet R, Frisoni GB, Jovicich J; PharmaCog Consortium..
Hum Brain Mapp. 2015 Sep;36(9):3516-27. doi: 10.1002/hbm.22859.
> Physical Activity and Amyloid-β Brain Levels in Elderly Adults with Intact Cognition and Mild Cognitive Impairment.
de Souto Barreto P, Andrieu S, Payoux P, Demougeot L, Rolland Y, Vellas B; Multidomain Alzheimer Preventive Trial/Data Sharing Alzheimer Study Group..
J Am Geriatr Soc. 2015 Aug;63(8):1634-9. doi: 10.1111/jgs.13530.
> Radiolabeling of [18F]-fluoroethylnormemantine and initial in vivo evaluation of this innovative PET tracer for imaging the PCP sites of NMDA receptors.
Salabert AS, Fonta C, Fontan C, Adel D, Alonso M, Pestourie C, Belhadj-Tahar H, Tafani M, Payoux P.
Nucl Med Biol. 2015 Aug;42(8):643-53. doi: 10.1016/j.nucmedbio.2015.04.001.
> Radiolabelling rituximab with (99m)Tc in three steps procedure.
Fontan C, Bezombes C, Salabert AS, Costes J, Lopez R, Fournie JJ, Avet-Loiseau H, Coulais Y, Payoux P, Tafani M.J
Labelled Comp Radiopharm. 2015 Jun 15;58(7):274-80. doi: 10.1002/jlcr.3283.
> Precuneus and Cingulate Cortex Atrophy and Hypometabolism in Patients with Alzheimer’s Disease and Mild Cognitive Impairment: MRI and (18)F-FDG PET Quantitative Analysis Using FreeSurfer.
Bailly M, Destrieux C, Hommet C, Mondon K, Cottier JP, Beaufils E, Vierron E, Vercouillie J, Ibazizene M, Voisin T, Payoux P, Barré L, Camus V, Guilloteau D, Ribeiro MJ.
Biomed Res Int. 2015;2015:583931. doi: 10.1155/2015/583931.
> Multisite longitudinal reliability of tract-based spatial statistics in diffusion tensor imaging of healthy elderly subjects.
Jovicich J, Marizzoni M, Bosch B, Bartrés-Faz D, Arnold J, Benninghoff J, Wiltfang J, Roccatagliata L, Picco A, Nobili F, Blin O, Bombois S, Lopes R, Bordet R, Chanoine V, Ranjeva JP, Didic M, Gros-Dagnac H, Payoux P, Zoccatelli G, Alessandrini F, Beltramello A, Bargalló N, Ferretti A, Caulo M, Aiello M, Ragucci M, Soricelli A, Salvadori N, Tarducci R, Floridi P, Tsolaki M, Constantinidis M, Drevelegas A, Rossini PM, Marra C, Otto J, Reiss-Zimmermann M, Hoffmann KT, Galluzzi S, Frisoni GB; PharmaCog Consortium..
Neuroimage. 2014 Nov 1;101:390-403. doi: 10.1016/j.neuroimage.2014.06.075.
> A case of logopenic primary progressive aphasia with C9ORF72 expansion and cortical florbetapir binding.
Saint-Aubert L, Sagot C, Wallon D, Hannequin D, Payoux P, Nemmi F, Bezy C, Chauveau N, Campion D, Puel M, Chollet F, Pariente J.
J Alzheimers Dis. 2014;42(2):413-20. doi: 10.3233/JAD-140222.
> Insight on AV-45 binding in white and grey matter from histogram analysis: a study on early Alzheimer’s disease patients and healthy subjects.
Nemmi F, Saint-Aubert L, Adel D, Salabert AS, Pariente J, Barbeau EJ, Payoux P, Péran P.
Eur J Nucl Med Mol Imaging. 2014 Jul;41(7):1408-18. doi: 10.1007/s00259-014-2728-4.
> MAPT STUDY: A MULTIDOMAIN APPROACH FOR PREVENTING ALZHEIMER’S DISEASE: DESIGN AND BASELINE DATA.
Vellas B, Carrie I, Gillette-Guyonnet S, Touchon J, Dantoine T, Dartigues JF, Cuffi MN, Bordes S, Gasnier Y, Robert P, Bories L, Rouaud O, Desclaux F, Sudres K, Bonnefoy M, Pesce A, Dufouil C, Lehericy S, Chupin M, Mangin JF, Payoux P, Adel D, Legrand P, Catheline D, Kanony C, Zaim M, Molinier L, Costa N, Delrieu J, Voisin T, Faisant C, Lala F, Nourhashémi F, Rolland Y, Van Kan GA, Dupuy C, Cantet C, Cestac P, Belleville S, Willis S, Cesari M, Weiner MW, Soto ME, Ousset PJ, Andrieu S.
J Prev Alzheimers Dis. 2014 Jun;1(1):13-22.
> Comparison between PET template-based method and MRI-based method for cortical quantification of florbetapir (AV-45) uptake in vivo.
Saint-Aubert L, Nemmi F, Péran P, Barbeau EJ, Payoux P, Chollet F, Pariente J.
Eur J Nucl Med Mol Imaging. 2014 May;41(5):836-43. doi: 10.1007/s00259-013-2656-8.